Manufacturing and Analytical Characterization - Chemical

(W0930-11-60) Case Study Approach of an Excipient Compaction Assessment to Support Dual Sourcing

(T0930-11-61) Elevating Liposomal Formulation Analysis: An Advanced CE-C4D Method for Quantification of Ionic Excipients in Liposomal Doxorubicin

(M0930-11-61) Investigating Impact of Food Induced Fluid Viscosity on Immediate Release Tablet Disintegration and Drug Dissolution

(W0930-11-61) Quantitative and Qualitative Analysis of Lipids and Cholesterol Derivatives in SMOF Lipids 20% Intravenous Lipid Emulsion

(W0930-11-62) Quantification of Novel Racemic Compound of Guaifenesin in Commercial Conglomerate Material Using Powder X-ray Diffraction

(T0930-11-62) Strategic Optimization and Evaluation of Stress Conditions for IgG4 Antibodies

(M0930-11-62) Topical Creams Sensorial Perception: Correlation with Product Critical Quality Attributes

(W0930-11-63) Improving Adhesion Evaluation of Transdermal Rotigotine Patches: Utilizing Skin-Mimicking Substrates for Accurate Assessment

(T0930-11-63) Solid-State NMR and FTIR Reveal Moisture-Triggered Adhesion Loss in Rotigotine Patches

(M0930-11-63) The Effect of Annealing Temperature and Composition on Lyophilized Sucrose / Glycine Formulations

(W0930-11-64) Developing an Assessment Framework, Items, and Expert Reviews for an Educational Instrument for the Proper Use of the USP/NF Pharmacopeia

(M0930-11-64) Low Surface Area Measurements of Excipients, Replacing Krypton with Nitrogen

(M0930-11-65) Optimization of a Mini-Tablet Compression Process

(T0930-11-65) Quantitative Prediction of Segregation Risk in Multicomponent Pharmaceutical Blends

(W0930-11-65) Transfer of a Low Dose Formulation from Batch to Continuous Manufacturing: High-Shear Wet Granulation to Continuous Twin-Screw Wet Granulation

(W1030-10-55) Optimizing Tablet Formulation through Integrated Use of Digital Formulation Tools and Compaction Simulation

(W1030-10-56) Validation and Application of an LC-MS/MS Method to Evaluate In Vitro Permeation of Naloxone Nasal Spray Using Artificial Substrate

(W1030-10-57) The Effect of Food Vehicle on In Vitro Performance of Mini-Tablets Formulation

(W1030-10-58) Next-Generation Bio-Inert HPLC System for Enhanced Analysis of Biotherapeutics

(W1030-10-59) Optimization of Assay Method for a Drug with Two pKa

(W1030-11-60) Canada and the World: A Comparative Global Regulatory and Quality Variability Study of Melatonin Health Products

(M1030-11-61) Capsule Customization: Pioneering Automated Production of Patient-Specific Poly-Pills

(T1030-11-61) Comprehensive Composition Analysis of Doxorubicin HCl Liposomes

(W1030-11-61) Sending Ritonavir to Space and Back – Drug Development Enabled by Specially Designed Hardware to Perform in Microgravity

(T1030-11-62) Impacts of Method Conditions and Autosampler Characteristics on Method Migration

(M1030-11-62) Orthogonal Measurement of Number Concentration Standards for NTA Calibration

(W1030-11-62) Production of Drug Nanocrystals Using a Cost-Effective Miniaturised Media Milling Approach

(W1030-11-63) Crystalline Craftsmanship: Controlling Surface Roughness of Spray-Freeze-Dried Particles

(M1030-11-63) Investigation of Interplay between API Processing Method and Modified Release Matrix Tablet on Dissolution Performance

(T1030-11-63) Twin Screw Extrusion Process Design and Die Modeling for Directly Extruded Implants

(T1030-11-64) Mechanistic Prediction of Tablet Breaking Force for Binary Blends Based on Individual Component Properties

(M1030-11-65) Characterization of Long-Acting Injectable Formulation for Pre-Clinical Studies Using Accelerated In Vitro Release (IVR) Technique

(T1030-11-65) Formulation in a Droplet – a Material Sparing Approach to Wet Granulation Formulation Screening

(T1130-10-54) Developing Robust Control Strategies for an Unexpected Fluorination Process Investigation

(W1130-10-54) Streamlining Pharmaceutical Process Development: A User-Centric Approach to High-Throughput Analysis

(W1130-10-55) Improving Sensitivity and Accuracy in Nitrite Measurement in Hydroxypropyl Methylcellulose

(T1130-10-55) Physicochemical Stability Investigation of Insulin in a Mesoporous Carrier Used for Oral Delivery

(W1130-10-56) Mechanistic Evaluation of Microstructure and Performance Attributes of Medicated Topical Shampoos

(M1130-10-56) Near-Infrared Assessment: A Potential Rapid Screening Tool for Pharmaceutical Quality Assessment

(T1130-10-56) Understanding Friability Performance in Titanium-Free Film Coated Tablets as a Function of Tablet Shape and Core Composition

(W1130-10-57) Assessing Topical Dosage Form Manufacturing Methods and Their Impact on Globule Microstructure with Non-Invasive Micro-CT Analysis

(M1130-10-57) Evaluation of Lubricant Distribution in Tablets Using All-in-One Excipients

(T1130-10-57) Preparation of Nebulised Luteolin-Loaded Nano-formulations as a Potential Management for Pulmonary Atrial Hypertension

(T1130-10-58) Effective Product Life-Cycle Management Through Continued Process Verification (Stage 3) Using Statistical Software

(M1130-10-58) Mechanistic Investigation of Gamma Irradiation Effects on Physicochemical Stability of Excipients Used in Colloidal Injectable Suspensions

(M1130-10-59) Prediction of Maximum Drug Loading in a Tablet Using Percolation Theory

(T1130-10-59) Quality Assessment of Four FDA-Approved Extended-Release Products of Divalproex

(M1130-11-60) Effect of Medium Viscosity on Swelling and Disintegration of Immediate Release Solid Oral Tablet

(M1130-11-61) Development of Biorelevant Dissolution Methods for Potential Risk-Based Biowaivers of BCS Class IIa Compounds: Impact of pH, Buffer Capacity and Hydrodynamics of Dissolution Media

(T1130-11-61) The Role of Filtration in Maintaining HPLC Data Quality

(M1130-11-62) Network Analysis of Pharmaceutical Products from Hong Kong PIC/S GMP Manufacturers

(T1130-11-63) Optical Radiocarbon (¹⁴C) Tracing for Biological and Pharmaceutical Applications

(M1130-11-63) Synthesis of Novel Surfactant for Formulating Cationic Nanoparticles

(M1130-11-64) Decreased Crystal Plasticity by Solvation-The Case of Levofloxacin Acesulfame

(W1130-11-64) Reverse Engineering of the Sublocade^® Buprenorphine In Situ Forming Implant

(T1130-11-65) Application of Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS) to Investigate Tablet Behaviour in Aqueous Media

(W1230-11-60) Development and Validation of Analytical Methodology by Uv-Vis Spectrophotometry for D-Limonene Quantification

(M1230-11-60) The Effect of Conventional Cooling Versus Controlled Ice Nucleation on Primary Drying Time

(W1230-11-61) In Situ Monitoring of Dissolution and Crystallization Processes for Active Pharmaceutical Ingredients Using Low Frequency Raman Spectroscopy

(T1230-11-61) Reaching an Optimum Calibration-Free Solution: The Role of Numerical Solver Parameters on IOT Prediction of Active Ingredients in Pharmaceutical Powder Blends

(T1230-11-62) Chemical Stability of Ritonavir Crystallized in Space

(M1230-11-62) Physical Stability of Ritonavir Crystallized in Space

(T1230-11-63) Laser Directed Infrared (LDIR) Imaging to Track the Evolution of Polymorphic Transformation During Stability Studies on Ritonavir Tablets

(M1230-11-63) Prediction Model for the Dry Film Thickness in the Continuous Manufacturing of Oral Films

(M1230-11-64) A New Insight into the Effect of the Process Conditions on the Permeability of Powders

(T1230-11-64) Roller Compaction Simulation Reproducible Milling Technologies Between Lab Scale and Pilote Scale

(T1230-11-65) Epinephrine Degradation in Pediatric Auto-Injectors

(M1230-11-65) Local Heat Generation at Kneading Zone in Continuous Twin-Screw Melt Granulation: Exploring the Interplay of Processing Parameters and Binder Level for a Novel Thermal Binder

(T1330-10-54) Continuous Manufacturing: Rheological Powder Characterisation of Excipients to Understand Their Behaving during the Feeding Step

(M1330-10-54) DSC vs. DVS: Determining the Moisture-Induced Tg vs. RH of Hygroscopic Materials

(M1330-10-55) Evaluation of Critical Microstructural and Performance Attributes of Azelaic Acid Topical Gels

(M1330-10-56) Comparative Study of Suitability for Wet Continuous Manufacturing Process Using MCC with Different Characteristics - Part 2

(T1330-10-56) Development of Inhaled Dry Powder Using Electrospinning Method

(M1330-10-57) Enhancing Tablet Manufacturing Flexibility: Design Space Determination with Compaction Simulator

(T1330-10-57) Material Sparing Approaches for Preparation of Amorphous Solid Dispersions

(M1330-10-58) A Multiple Component, Indirect Analysis of Ammonium: Analysis of Sulfate Ion in a Commercial Biotherapeutic via HPLC to Measure Ammonium Content

(M1330-10-59) Dissolution Method Development for Amorphous Solid Dispersions-Based Oral Drug Products

(T1330-10-59) High Shear Wet Granulation Scale-Up Using Basic Principles

(T1330-11-61) NIR-Based Quality Analytics for Semisolid Extrusion 3D Drug Printing

(M1330-11-61) Performance Verification Variations Within Mechanical Calibration Allowance of Paddle Apparatus with Standard and Apex Vessels

(T1330-11-62) Laboratory Study in Gastric Nitrosamine Formation

(M1330-11-62) Simultaneous Detection of Camostat/Niclosamide Cocrystal and Its Related Impurities via Analytical Quality by Design

(T1330-11-63) Developing a Risk Score for Critical Suppliers Using Artificial Intelligence (AI)

(T1330-11-64) A Novel Material-Sparing Degradation Kinetics Approach for Feasibility Assessment of Twin-Screw Melt Granulation

(M1330-11-65) Compression Process Optimzation Using 2³ Full Factorial Design of Experiments

(T1330-11-65) Considerations for Drug layering of Sitagliptin on Placebo Tablets to Manufacture Fixed Dose Combination Drug Products

(M1430-10-54) Designing Spray Dried Particles with a Pressure Nozzle at Small Scale

(T1430-10-54) Drug Particle Size Change of a Hydrophobic Drug and Its Impact on Dissolution after Twin-Screw Wet Granulation

(M1430-10-55) Formulation Development of High Drug Loaded, Stable Amorphous Solid Dispersions (ASDs) Through Spray Drying: An Industrial Perspective Case Study

(T1430-10-55) Manual 2D LC-MS for Peak Purity Assessment of Atropisomeric Compound

(T1430-10-56) High-Throughput Analytical: Development of New High-Throughput Experimentation and Analytics Capabilities

(M1430-10-56) Material Sparing Dry Granulation via RoCo Simulation Enables Technical Transfer of SDI-Based Formulations

(M1430-10-57) Development of a Single-Vial Drug Release Assay Utilizing Bio-Beads SM-2 Resin to Evaluate Doxorubicin Liposomes

(T1430-10-57) Envisioning New Concepts for 3D Printing and Solubility Enhancement: Tablet Manufacturing of Loaded Parteck^® SLC through Z-Form Binder Jetting Technology

(M1430-10-58) Rapid Material-Sparing Approach to Address Hairline Fractures in Low Drug Load Tablets via Compaction Simulation

(T1430-10-58) Understanding Nitrite Loss in Pharmaceutical Drug Products and its Impact on N‑Nitrosamine Formation

(T1430-10-59) Enhanced Versatility of a Novel Coating Methods of Fine Particles for Time-Saving

(M1430-10-59) High Drug Load Metformin ER 1000 mg Tablets Processed via Roller Compaction in Combination with High Molecular Weight HPC

(T1430-11-60) Determining Impact of Particle Size and Crystal Quality on Formation of Nitrosamine in API and Drug Formulations

(T1430-11-61) Predictive Residence Time Distribution Models for Continuous Powder Blending

(M1430-11-61) Toward Improving the In Vitro, In Vivo Correlation of Lipid-Based Formulations Using a Simplified Gastro-Intestinal Lipolysis Protocol

(T1430-11-62) What Is That Peak in Hydrocodone Bitartrate USP Reference Standard?

(T1430-11-63) Advancements in Sustainable Moisture Activated Dry Granulation: Optimizing Excipients and Process for Diosmin 500 mg Tablet Formulation

(M1430-11-63) Going Greener with the USP 621 Globally Harmonized Pharmacopeial Guidance for Liquid Chromatography

(T1430-11-64) Reducing Cycle Time While Maintaining Acceptable Granule and Tablet Properties for a Semi-Continuous Fluidized Bed Granulation Process

(M1430-11-64) System Robustness and Best Practices of a High Throughput LC-MS Method for Cell Culture Media Nutrient and Metabolite Analysis

(M1430-11-65) Particle Engineering Approach to Formulating Hot Melt Extrusion Amorphous Solid Dispersion Tablets

(T1430-11-65) Unraveling the Impact of Polymeric Material Attributes in Semisolid Products: Paving the Way for Consistent Viscosity Profile Across Commercial Batches

(T1530-10-54) High-Speed Compound Quality Assessment Using Acoustic Ejection Mass Spectrometry

(T1530-11-60) Evaluation of Near Infrared (NIR) for the Quantitation of Low Dose Drugs

(M1530-11-62) Method Development and Validation for Leachable Silicone Oil in Pharmaceutical Drug Products by Graphite Furnace AAS

(T1530-11-62) The Necessity of Using LC-MS/MS Technology to Investigate the Presence of N-Nitrosamines Impurities in Pharmaceutical Drug Products

(T1530-11-63) Development of the USP Chapter < 1762 > for Solid-State Nuclear Magnetic Resonance Spectroscopy

(M1530-11-63) Safe and Effective Analysis of High Potency Compounds Using Solid-State NMR Spectroscopy

(T1530-11-64) A Rational Approach to Scaling-Up Lubrication in Pharmaceutical Tablet Manufacturing

(T1530-11-65) Developing a Spray Flux Equation for a Semi-Continuous Fluid Bed Granulation System

(M1530-11-65) Investigation of Dissolution and Permeation Properties of Amorphous Drug Particles Dispersed in Wax-Based Formulations